H R Rosen
Overview
Explore the profile of H R Rosen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
1232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosen H, Boedecker C, Furst A, Kramer G, Hebenstreit J, Kneist W
Tech Coloproctol
. 2020 Jun;
24(12):1247-1253.
PMID: 32562153
Background: Low anterior resection syndrome (LARS) is associated with a severe negative impact on patients' quality of life (QOL). In a recent prospective randomized controlled trial (RCT) by our group,...
2.
Rosen H, Kneist W, Furst A, Kramer G, Hebenstreit J, Schiemer J
BJS Open
. 2019 Aug;
3(4):461-465.
PMID: 31388638
Background: Low anterior resection syndrome (LARS) is a frequent problem after rectal resection. Transanal irrigation (TAI) has been suggested as an effective treatment in patients who have developed LARS. This...
3.
Burchill M, Golden-Mason L, Wind-Rotolo M, Rosen H
J Viral Hepat
. 2015 Oct;
22(12):983-91.
PMID: 26482547
Recently, the treatment of HCV has advanced significantly due to the introduction of direct-acting antivirals (DAAs). Studies using interferon (IFN)-containing regimens failed to consistently show restoration of immunologic responses. Therefore,...
4.
Biggins S, Gralla J, Dodge J, Bambha K, Tong S, Baron A, et al.
Am J Transplant
. 2014 Sep;
14(11):2588-94.
PMID: 25243648
Survival benefit (SB) for first liver transplantation (LT) is favorable at Model for End-Stage Liver Disease (MELD)≥15. Herein, we identify the MELD threshold for SB from repeat liver transplantation (ReLT)...
5.
Yanagisawa K, Yue S, van der Vliet H, Wang R, Alatrakchi N, Golden-Mason L, et al.
J Viral Hepat
. 2013 Jul;
20(8):556-65.
PMID: 23808994
Hepatic CD1d-restricted and natural killer T-cell populations are heterogeneous. Classical 'type 1' α-galactosylceramide-reactive CD1d-restricted T cells express 'invariant' TCRα ('iNKT'). iNKT dominating rodent liver are implicated in inflammation, including in...
6.
Holzer B, Rosen H, Urban M, Anzbock W, Schiessel R, Hruby W
Colorectal Dis
. 2013 Apr;
2(6):340-5.
PMID: 23578152
Objective: MRI has been reported to be valuable in the investigation of patients with fistula in ano. The aim of this study was to evaluate the results of preoperative magnetic...
7.
Mengshol J, Golden-Mason L, Castelblanco N, Im K, Dillon S, Wilson C, et al.
Gut
. 2009 Feb;
58(7):964-73.
PMID: 19193669
Background: Dendritic cell (DC) defects may contribute to chronicity in hepatitis C virus (HCV) infection and determine response to PEG-interferon and ribavirin therapy via poor T cell stimulation. Studies to...
8.
Rhodes S, Erlich H, Im K, Wang J, Li J, Bugawan T, et al.
Genes Immun
. 2008 Apr;
9(4):328-33.
PMID: 18418397
The human major histocompatability complex (MHC) genes encode the human leukocyte antigens, which are important in antigen presentation and regulation of CD8+ and CD4+ T cells. Response to therapies in...
9.
Holzer B, Rosen H, Novi G, Ausch C, Holbling N, Hofmann M, et al.
Dis Colon Rectum
. 2008 Mar;
51(5):524-29.
PMID: 18322757
Purpose: Constipation is frequently a multifactorial disease. This study was designed to evaluate the potential effects of sacral nerve stimulation for patients suffering from severe chronic constipation. Methods: Nineteen patients...
10.
Arjal R, Burton Jr J, Villamil F, Rosen H
Aliment Pharmacol Ther
. 2007 Jun;
26(2):127-40.
PMID: 17593060
Background: Recurrent hepatitis C represents a major challenge for the liver transplant community. Given the potentially significant impact that hepatitis C recurrence has on graft and patient survival, several treatment...